Bill > HB06097

This bill requires pharmacy benefit managers, pharmacies, insurers, and hospitals that dispense, prescribe, or provide coverage for prescription drugs under Section 340B of the Public Health Service Act to submit a report to the Office of Health Strategy detailing the cost charged to consumers for these discounted drugs. Section 340B is a federal program that allows certain healthcare providers to purchase outpatient drugs at significantly reduced prices, with the aim of helping healthcare organizations that serve vulnerable populations. The bill's purpose is to increase transparency and ensure that consumers are actually receiving the financial benefits of these drug discounts, preventing potential overcharging or inappropriate Medicaid enrollment practices that might incorrectly calculate a patient's income based on prescription drug costs. By mandating these reports, the legislation seeks to provide oversight and protect consumers from potential financial exploitation in the prescription drug market.

Health and Social Services

https://www.cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&bill_num=HB06097&which_year=2025